These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11427637)

  • 1. Methylene blue, a nitric oxide inhibitor, prevents haemodialysis hypotension.
    Peer G; Itzhakov E; Wollman Y; Chernihovsky T; Grosskopf I; Segev D; Silverberg D; Blum M; Schwartz D; Iaina A
    Nephrol Dial Transplant; 2001 Jul; 16(7):1436-41. PubMed ID: 11427637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma adrenomedullin levels in hemodialysis patients with sustained hypotension.
    Cases A; Esforzado N; Lario S; Vera M; Lopez-Pedret J; Rivera-Fillat F; Jimenez W
    Kidney Int; 2000 Feb; 57(2):664-70. PubMed ID: 10652045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of nitric oxide in haemodialysis hypotension.
    Nishimura M; Takahashi H; Yoshimura M
    Acta Physiol Scand; 2000 Jan; 168(1):181-6. PubMed ID: 10691798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced production of nitric oxide may be involved in acute hypotension during maintenance hemodialysis.
    Nishimura M; Takahashi H; Maruyama K; Ohtsuka K; Nanbu A; Hara K; Yoshimura M
    Am J Kidney Dis; 1998 May; 31(5):809-17. PubMed ID: 9590191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of asymmetric dimethylarginine to haemodialysis hypotension.
    Bergamini S; Vandelli L; Bellei E; Rota C; Manfredini P; Tomasi A; Albertazzi A; Iannone A
    Nitric Oxide; 2004 Nov; 11(3):273-8. PubMed ID: 15566974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium ramping reduces hypotension and symptoms during haemodialysis.
    Tang HL; Wong SH; Chu KH; Lee W; Cheuk A; Tang CM; Kong IL; Fung KS; Tsang WK; Chan HW; Tong KL
    Hong Kong Med J; 2006 Feb; 12(1):10-4. PubMed ID: 16495583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased nitric oxide production in patients with hypotension during hemodialysis.
    Yokokawa K; Mankus R; Saklayen MG; Kohno M; Yasunari K; Minami M; Kano H; Horio T; Takeda T; Mandel AK
    Ann Intern Med; 1995 Jul; 123(1):35-7. PubMed ID: 7762912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hypotension in hemodialysis patients: role of functional vascular changes and vasodilator agents.
    Coll E; Larrousse M; de la Sierra A; Collado S; Jiménez W; Cases A
    Clin Nephrol; 2008 Feb; 69(2):114-20. PubMed ID: 18365352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of asymmetric dimethylarginine to hemodialysis-associated hypotension in end-stage renal disease patients.
    Csiky B; Sulyok E; Lakatos O; Wittmann I; Martens-Lobenhoffer J; Bode-Boger SM
    Nephron Clin Pract; 2008; 108(2):c127-34. PubMed ID: 18230915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of methylene blue in the treatment of anaphylactic shock induced by compound 48/80: experimental studies in rabbits.
    Buzato MA; Viaro F; Piccinato CE; Evora PR
    Shock; 2005 Jun; 23(6):582-7. PubMed ID: 15897814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can haemodialysis-induced hypotension be predicted?
    Cai Y; Zimmerman A; Ladefoged S; Secher NH
    Nephron; 2002; 92(3):582-8. PubMed ID: 12372941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin.
    Raj DS; Vincent B; Simpson K; Sato E; Jones KL; Welbourne TC; Levi M; Shah V; Blandon P; Zager P; Robbins RA
    Kidney Int; 2002 Feb; 61(2):697-704. PubMed ID: 11849413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible sequestration of nitric oxide by hemoglobin during hemodialysis in end-stage renal disease.
    Kang ES; Miles DE; Tevlin MT; Cates TB; Acchiardo SR
    Am J Med Sci; 2001 Feb; 321(2):113-23. PubMed ID: 11217813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biofeedback controlled hemodialysis (BF-HD) reduces symptoms and increases both hemodynamic tolerability and dialysis adequacy in non-hypotension prone stable patients.
    McIntyre CW; Lambie SH; Fluck RJ
    Clin Nephrol; 2003 Aug; 60(2):105-12. PubMed ID: 12940612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodialysis hypotension and nitric oxide production: comparison of heparin with parnaparin.
    Arici M; Altun B; Dinler O; Kiykim AA; Usalan C; Erdem Y; Yasavul U; Turgan C; Cağlar S
    Blood Purif; 2002; 20(2):145-9. PubMed ID: 11818676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased nitric oxide production in hypotensive hemodialysis patients.
    Lin SH; Chu P; Yu FC; Diang LK; Lin YF
    ASAIO J; 1996; 42(5):M895-9. PubMed ID: 8945014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysate calcium profiling during hemodialysis: use and clinical implications.
    Kyriazis J; Glotsos J; Bilirakis L; Smirnioudis N; Tripolitou M; Georgiakodis F; Grimani I
    Kidney Int; 2002 Jan; 61(1):276-87. PubMed ID: 11786110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of intradialytic complications at the Lagos University Teaching Hospital.
    Amira CO; Braimoh RW; Bello BT
    Afr J Med Med Sci; 2012 Dec; 41(4):411-6. PubMed ID: 23672106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide production and blood pressure reduction during haemodialysis.
    Chang CT; Chien MH; Yang KL; Yu CC; Hsu JF; Wang IK; Lim PS; Huang CC
    Nephrology (Carlton); 2014 Sep; 19(9):562-7. PubMed ID: 24839907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postsynaptic adrenergic unresponsiveness in hypotensive haemodialysis patients.
    Botey A; Gaya J; Montoliu J; Torras A; Rivera F; López-Pedret J; Revert L
    Proc Eur Dial Transplant Assoc; 1981; 18():586-91. PubMed ID: 7329986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.